Access to quality vaccines, medicines, and health technologies in Rwanda

KWIGIRA
Rwanda

Korte inhoud project

The KWIGIRA project, Access to quality vaccines, medicines, and health technologies in Rwanda aims to strengthen entrepreneurship and to improve the business environment and attractiveness of Rwanda for pharmaceutical investments in order to ensure access to quality vaccines, medicines, and health technologies in Africa.

Code RWA21001
Startdatum 18 April 2022
Einddatum 18 April 2026
Fase Execution
Donor European Union
Sector 25010 Business support services and institutions
Budget 7 042 056.00 €

Algemene doelstelling

The business environment and attractiveness of Rwanda for pharmaceutical investments is enhanced to ensure access to quality vaccines, medicines, and health technologies in Africa

Specifieke doelstellingen

A - To assist Rwanda FDA to adequately perform its mission to protect public health and to reach and maintain maturity level 3 of WHO Global Benchmarking Tool (GBT) to fully regulate pharmaceutical products including vaccines manufacturing in Rwanda.

Nieuws

Geen nieuws

Links
  • Geen links
Documenten
  • Geen documenten
Exporteer de gegevens